Investor Overview
 |
KindredBio is focused on bringing breakthrough human products and innovative new technologies to veterinary medicine to address unmet clinical needs and provide benefits to animal co...
Stock Information
NASDAQ CM$9.34NEWS
Kindred Biosciences to Announce First Quarter 2019 Financial Results
April 25, 2019
Company to Hold Conference Call and Webcast at 4:30 p.m. Eastern Time / 1:30 p.m...
Kindred Biosciences Announces Fourth Quarter and Full Year 2018 Financial Results
March 6, 2019
SAN FRANCISCO, March 6, 2019 /PRNewswire/ -- Kindred Biosciences, Inc. (NASDAQ: ...
Kindred Biosciences to Announce Fourth Quarter and Year-End 2018 Financial Results
February 19, 2019
Company to Hold Conference Call and Webcast at 4:30 p.m. Eastern Time / 1:30 p.m...